The Ceftazidime for Injection, cataloged under National Stock Number 6505-01-268-3578, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Eli Lilly and Company. Government technical data includes 8 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-268-3578 |
| Primary Part Number | NDC00002-7246-24 |
| Item Name | Ceftazidime for Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Total Primary Container Quantity | 24 |
| Active Medicament Medicinal Strength | 2.0 GRAMS CEFTAZIDIME ACTIVE INGREDIENT G |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Content Quantity | 2.000 GRAMS G |
| Physical Form | POWDER |
| Primary Container Type | BAG, PLASTIC |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| NDC00002-7246-24 PRIMARY | Eli Lilly and Company (USA) |
| TAZIDIME FASPAK | Eli Lilly and Company (USA) |
| 7246 PRIMARY | Eli Lilly and Company (USA) |
NSN 6505-01-268-3578 is a Ceftazidime for Injection, manufactured by Eli Lilly and Company, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-268-3578 has 3 cross-referenced part numbers: NDC00002-7246-24 (Eli Lilly and Company), TAZIDIME FASPAK (Eli Lilly and Company), 7246 (Eli Lilly and Company).
There are 12 known substitutes for 6505-01-268-3578: 3110-00-100-0719, 5905-00-230-8029, 5940-00-264-9099 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00002-7246-24: Administration: INTRAVENOUS; Total Primary Container Quantity: 24; Active Medicament Medicinal Strength: 2.0 GRAMS CEFTAZIDIME ACTIVE INGREDIENT G; Part Name Assigned by Controlling Agency: CEFTAZIDIME FOR INJECTION. 9 total characteristics are documented in the Federal Logistics Information System.